Browsing by Subject "Cernunnos-XLF deficiency"

Sort by: Order: Results:

  • Slack, J; Albert, MH; Balashov, D; Belohradsky, BH; Bertaina, A; Bleesing, J; Booth, C; Büchner, J; Buckley, Rebecca Hatcher; Ouachée-Chardin, M; Deripapa, E; Drabko, K; Eapen, M; Feuchtinger, T; Finocchi, A; Gaspar, HB; Ghosh, S; Gillio, A; Gonzalez-Granado, LI; Grunebaum, E; Güngör, T; Heilmann, C; Helminen, M; Higuchi, K; Imai, K; Kalwak, K; Kanazawa, N; Karasu, G; Kucuk, ZY; Laberko, A; Lange, A; Mahlaoui, N; Meisel, R; Moshous, D; Muramatsu, H; Parikh, S; Pasic, S; Schmid, I; Schuetz, C; Schulz, A; Schultz, KR; Shaw, PJ; Slatter, MA; Sykora, K-W; Tamura, S; Taskinen, M; Wawer, A; Wolska-Kus Nierz, B; Cowan, MJ; Fischer, A; Gennery, AR; Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation; European Society for Immunodeficiencies, Stem Cell Transplant for Immunodeficiencies in Europe (SCETIDE), the Center for International Blood and Marrow Transplant Research,; Primary Immunodeficiency Treatment Consortium (2017-04-06)
    BACKGROUND: Rare DNA breakage-repair disorders predispose to infection and lympho-reticular malignancies. Hematopoietic cell transplantation (HCT) is curative but co-administered chemo- or radio-therapy is damaging due to ...